Listed by the USPTO as THOMAN, EVELYN ANNE
Tech Center 3700 • Art Units: 3783
This examiner grants 100% of resolved cases
THOMAN, EVELYN ANNE is a USPTO patent examiner in tech center 3700 and art unit 3783. The profile contains 1 resolved case, an allowance rate of 100.0%, and a median of 1162 days to allowance. The interview lift is 0.0%.
The listed companies are Terumo Corporation, Sanofi S.A., and Aita Bio Inc. The listed firms are Bond, Schoeneck & King, PLLC - SANOFI, Davidson Kappel LLC - AiTA Bio, and FOLEY & LARDNER LLP. The single resolved case limits the predictive value of the outcome figures. The interview measure shows no reported lift, so practitioners should rely on the application-specific record when deciding whether an interview is warranted.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18123778 | Handheld, Untethered Catheter Containment System and Method | Final Rejection | Bard Access Systems, Inc. |
| 18752565 | REMOVABLE LUNG ISOLATION DEVICE FOR LOCALIZED DRUG THERAPY | Non-Final OA | Covidien LP |
| 17970740 | SYSTEMS AND METHODS FOR PRODUCING MIXTURES | Final Rejection | Boston Scientific Scimed, Inc. |
| 18900051 | LIQUID MEDICINE ADMINISTRATION DEVICE | Non-Final OA | TERUMO KABUSHIKI KAISHA |
| 18899321 | INFUSION SOLUTION OXYGENATION DEVICE AND INFUSION SOLUTION OXYGENATION SYSTEM | Non-Final OA | TERUMO KABUSHIKI KAISHA |
| 18796699 | MEDICINAL SOLUTION ADMINISTRATION DEVICE | Non-Final OA | TERUMO KABUSHIKI KAISHA |
| 18725277 | PUMP INTERCONNECTIVITY FOR PAIN MEDICATION THERAPIES | Non-Final OA | BAXTER HEALTHCARE SA |
| 18257189 | MAGNETIC RESONANCE IMAGING GUIDED ACTIVE INJECTION NEEDLE FOR RADIATION-ONCOLOGY BRACHYTHERAPY | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 18240708 | CATHETER | Final Rejection | ASAHI INTECC CO., LTD. |
| 18190572 | AUTONOMOUS ADAPTIVITY AND SET POINT CONTROL FOR A DRUG DELIVERY DEVICE | Non-Final OA | INSULET CORPORATION |
| 18909712 | PRESSURE SENSOR ASSEMBLY AND METHODS FOR INJECTION DEVICES | Non-Final OA | Sanofi |
| 18341368 | Supplementary Device for Attachment to an Injection Device | Non-Final OA | Sanofi |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy100.0% of resolved applications examined by Evelyn Anne Thoman were allowed (1 resolved cases), compared with 67.3% across Art Unit 3783 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Evelyn Anne Thoman took 1,162 days on average from filing to allowance.
Evelyn Anne Thoman examines applications in Art Unit 3783 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
